Insider Sale: President & CEO of $RARE (RARE) Sells 11,727 Shares

Quiver QuantitativeDec 31 14:15 ET

Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing

MT NewswiresDec 31 14:11 ET

H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $95

Moomoo NewsDec 24, 2024 06:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Springworks Therapeutics (SWTX)

TipRanksDec 24, 2024 06:20 ET · Ratings

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 20, 2024 16:30 ET

Express News | Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 20, 2024 16:30 ET